rs1340503453
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_ModerateBP6_Very_Strong
The NM_000321.3(RB1):c.540-9G>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000278 in 1,438,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000028 ( 0 hom. )
Consequence
RB1
NM_000321.3 splice_polypyrimidine_tract, intron
NM_000321.3 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0002723
2
Clinical Significance
Conservation
PhyloP100: 0.667
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 13-48348947-G-C is Benign according to our data. Variant chr13-48348947-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 458172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.540-9G>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000267163.6 | NP_000312.2 | |||
RB1 | NM_001407165.1 | c.540-9G>C | splice_polypyrimidine_tract_variant, intron_variant | NP_001394094.1 | ||||
RB1 | NM_001407166.1 | c.540-9G>C | splice_polypyrimidine_tract_variant, intron_variant | NP_001394095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.540-9G>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000321.3 | ENSP00000267163 | P1 | |||
RB1 | ENST00000467505.5 | c.138-11070G>C | intron_variant, NMD_transcript_variant | 1 | ENSP00000434702 | |||||
RB1 | ENST00000650461.1 | c.540-9G>C | splice_polypyrimidine_tract_variant, intron_variant | ENSP00000497193 | ||||||
RB1 | ENST00000525036.1 | n.702-9G>C | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000409 AC: 1AN: 244746Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 132688
GnomAD3 exomes
AF:
AC:
1
AN:
244746
Hom.:
AF XY:
AC XY:
0
AN XY:
132688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000278 AC: 4AN: 1438640Hom.: 0 Cov.: 30 AF XY: 0.00000559 AC XY: 4AN XY: 715466
GnomAD4 exome
AF:
AC:
4
AN:
1438640
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
715466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Retinoblastoma Benign:2
Likely benign, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 24, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at